Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shobana Balasingam

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2016
Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studiesShobana Balasingam, Annelies Wilder-Smith
The Journal of Antimicrobial Chemotherapy|December 23, 2003
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the communityJohn Oxford, Shobana Balasingam, Rob Lambkin
Singapore Medical Journal|October 3, 2014
The potential for a controlled human infection platform in SingaporeShobana Balasingam, Peter Horby, Annelies Wilder-Smith
Antiviral Chemistry & Chemotherapy|March 3, 2005
New antiviral drugs, vaccines and classic public health interventions against SARS coronavirusJohn S Oxford, Shobana Balasingam, Charlotte Chan, et al.
Antiviral Chemistry & Chemotherapy|May 14, 2005
A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoVJohn S Oxford, Robert Lambkin, Iain Gibb, et al.
Wellcome Open Research|May 4, 2022
Human infection studies: Key considerations for challenge agent development and productionShobana Balasingam, Sarah Meillon, Cecilia Chui, et al.
Current Topics in Microbiology and Immunology|June 15, 2022
A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit DesignJ S Oxford, A Catchpole, A Mann, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 13, 2024
Ethical approval for controlled human infectious model clinical trial protocols - A workshop reportEuzebiusz Jamrozik, Katherine Littler, Irina Meln, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesSumathy Velumani, Ying Xiu Toh, Shobana Balasingam, et al.
Vaccine|April 24, 2010
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccineOrli Even-Or, Sarit Samira, Eli Rochlin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 22, 2016
Randomized controlled trials for influenza drugs and vaccines: a review of controlled human infection studiesShobana Balasingam, Annelies Wilder-Smith
The Journal of Antimicrobial Chemotherapy|December 23, 2003
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the communityJohn Oxford, Shobana Balasingam, Rob Lambkin
Singapore Medical Journal|October 3, 2014
The potential for a controlled human infection platform in SingaporeShobana Balasingam, Peter Horby, Annelies Wilder-Smith
Antiviral Chemistry & Chemotherapy|March 3, 2005
New antiviral drugs, vaccines and classic public health interventions against SARS coronavirusJohn S Oxford, Shobana Balasingam, Charlotte Chan, et al.
Antiviral Chemistry & Chemotherapy|May 14, 2005
A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoVJohn S Oxford, Robert Lambkin, Iain Gibb, et al.
Wellcome Open Research|May 4, 2022
Human infection studies: Key considerations for challenge agent development and productionShobana Balasingam, Sarah Meillon, Cecilia Chui, et al.
Current Topics in Microbiology and Immunology|June 15, 2022
A Brief History of Human Challenge Studies (1900-2021) Emphasising the Virology, Regulatory and Ethical Requirements, Raison D'etre, Ethnography, Selection of Volunteers and Unit DesignJ S Oxford, A Catchpole, A Mann, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 13, 2024
Ethical approval for controlled human infectious model clinical trial protocols - A workshop reportEuzebiusz Jamrozik, Katherine Littler, Irina Meln, et al.
Human Vaccines & Immunotherapeutics|February 19, 2016
Low antibody titers 5 years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccineesSumathy Velumani, Ying Xiu Toh, Shobana Balasingam, et al.
Vaccine|April 24, 2010
Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccineOrli Even-Or, Sarit Samira, Eli Rochlin, et al.
Pageof 2